Ignota Labs

SAFEPATH: Causal AI-driven mechanistic understanding of drug safety failures

Ignota Labs have developed a novel AI platform to understand the root causes of safety problems in drug discovery. By combining Deep Learning models to predict how the drug interacts with the body, with algorithms over complex data, we can understand the biological impact of those interactions, enabling drug failure turnaround.




2024 finalists

Take a look at the finalists across the four competition categories